Clik here to view.
PF-06747775 (Pfizer) Third generation covalent EGFR inhibitors
PF-06747775 (Pfizer) PF06747775; PF06747775; PF 06747775; PF6747775; PF 6747775; PF6747775. PFE-X775...
View ArticleClik here to view.
AUNP-12 from Aurigene Discovery Technologies Limited
AUNP-12 AUR-012; Aurigene-012; NP-12, Aurigene; PD-1 inhibitor peptide (cancer), Aurigene; PD-1 inhibitor peptide (cancer), Aurigene/ Pierre Fabre; W-014A Company Aurigene Discovery Technologies...
View ArticleClik here to view.
GSK 1070916 For Advanced solid tumor
GSK 1070916 NMI-900 , GSK-1070916, GSK-1070916A 4-[3-(4-N,N-Dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridine...
View ArticleClik here to view.
(±)-Integrifolin, Compound from plants keeps human cancer cells from multipying
CAS 89647-87-0 MFC15 H18 O4, MW 262.30 Azuleno[4,5-b]furan-2(3H)-one, decahydro-4,8-dihydroxy-3,6,9-tris(methylene)-, (3aR,4R,6aR,8S,9aR,9bR)- Azuleno[4,5-b]furan-2(3H)-one,...
View ArticleClik here to view.
Chidamide (Epidaza), A New Cancer Drug, Made in China
Chidamide (Epidaza) CS055; HBI-8000 CAS 743438-44-0 CORRECT C22 H19 F N4 O2, Benzamide, N-(2-amino-4-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]- Molecular Weight, 390.41...
View ArticleClik here to view.
RO-5126766
RO-5126766 946128-88-7 MW 471.46 MF C21H18FN5O5S Phase I 3- [[2-[(Methylaminosulfonyl)amino]-3- fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]- 2H-1-benzopyran-2-one...
View ArticleClik here to view.
Consumption of a bioactive compound from Neem plant could significantly...
(From left to right) Principal Investigator Associate Professor Gautam Sethi and NUS PhD candidate Ms Zhang Jingwen from the Department of Pharmacology at the NUS Yong Loo Lin School of Medicine led a...
View ArticleClik here to view.
FDA grants accelerated approval to new treatment for advanced ovarian cancer...
The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for women with advanced...
View ArticleClik here to view.
Novartis Kisqali® (ribociclib, LEE011) receives FDA approval as first-line...
Approved based on a first-line Phase III trial that met its primary endpoint of progression-free survival (PFS) at interim analysis due to superior efficacy compared to letrozole alone[1] At this...
View ArticleClik here to view.
An insight into the therapeutic potential of quinazoline derivatives as...
The Food and Drug Administration (FDA) has approved several quinazoline derivatives for clinical use as anticancer drugs. These include gefitinib, erlotinib, lapatinib, afatinib, and vandetanib...
View ArticleClik here to view.
Prexasertib , прексасертиб , بريكساسيرتيب , 普瑞色替 ,
Prexasertib Captisol® enabled prexasertib; CHK1 Inhibitor II; LY 2606368; LY2606368 MsOH H2O 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile...
View ArticleClik here to view.
FDA approves new treatment for certain advanced or metastatic breast cancers
FDA approves new treatment for certain advanced or metastatic breast cancers The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone...
View ArticleClik here to view.
FDA approves first biosimilar Herceptin (trastuzumab) for the treatment of...
FDA approves first biosimilar for the treatment of certain breast and stomach cancers Ogivri, a biosimilar to the cancer drug Herceptin, is approved for HER2+ breast cancer and metastatic stomach...
View ArticleClik here to view.
Biocon Launches KRABEVA® in India, A Biosimilar Bevacizumab for Treating...
Biocon Launches KRABEVA® in India, A Biosimilar Bevacizumab for Treating Several Types of Cancer On November 23, 2017, Biocon India’s premier Biopharmaceuticals Company announced that it has launched...
View ArticleClik here to view.
TRILACICLIB, G1T28
Trilaciclib Molecular FormulaC24H30N8O Average mass446.548 Da G1T 28 CAS 1374743-00-6...
View ArticleClik here to view.
NASTORAZEPIDE
Nastorazepide (Z-360) CAS: 209219-38-5 Chemical Formula: C29H36N4O5 Molecular Weight: 520.61994 UNII-R22TMY97SG; 209219-38-5; Phase II, treatment of pancreatic cancer....
View ArticleClik here to view.
SEVITERONEL, севитеронел , سيفيتيرونيل , 赛维罗奈 ,
SEVITERONEL CAS Registry Number 1610537-15-9 Molecular formulaC18 H17 F4 N3 O3, MW 399.34 1H-1,2,3-Triazole-5-methanol, α-[6,7-bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-, (αS)-...
View ArticleClik here to view.
GFH 018
GFH-018 CAS 2169299-67-4 C21 H19 N7 O, 385.42 (E)-3-[6-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-5-yl]prop-2-enamide 2-Propenamide,...
View ArticleClik here to view.
TL 487
TL-487 CAS 1469746-55-1 2-Butenamide, N-[3-cyano-7-ethoxy-4-[(4-phenoxyphenyl)amino]-6-quinolinyl]-4-(dimethylamino)-, (2E)- Molecular Weight, 507.58, MF C30 H29 N5 O3 Teligene...
View ArticleClik here to view.
HS 10340
HS-10340 CAS 2156639-66-4 MF C26 H31 N7 O5 MW 521.57 1,8-Naphthyridine-1(2H)-carboxamide,...
View Article